Purdue Opioid Settlement Contingent on DOJ Probes
OxyContin maker Purdue Pharma LP’s plan to turn over its operations to creditors and see its owners, the Sacklers, exit the opioid business is contingent on resolving several criminal and civil probes by the U.S. Justice Department.
Source: The Crime Report ( TheCrimeReport.org )